The Rat Interleukin-1beta-Cell Lysates (IL-1β) ELISA quantitates rat IL-1β in rat cell or tissue lysates. The assay will exclusively recognize both natural and recombinant rat IL-1β. Principle of the method The rat IL-1β solid-phase sandwich ELISA…
Accession number
Q63264
Dose range
68.59-50.000 pg/ml
Sensitivity of the dosage
80 pg/ml
Calibration range
80 pg/ml to 50000 pg/ml
Dose
ELISA solid-phase sandwich
Brand
Invitrogen
The Rat Interleukin-1beta-Cell Lysates (IL-1β) ELISA quantitates rat IL-1β in rat cell or tissue lysates. The assay will exclusively recognize both natural and recombinant rat IL-1β. Principle of the method The rat IL-1β solid-phase sandwich ELISA…
The Rat Interleukin-1beta-Cell Lysates (IL-1β) ELISA quantitates rat IL-1β in rat cell or tissue lysates. The assay will exclusively recognize both natural and recombinant rat IL-1β. Principle of the method The rat IL-1β solid-phase sandwich ELISA (enzyme-linked immunosorbent assay) is designed to measure the amount of the target bound between a matched antibody pair. A target-specific antibody has been pre-coated in the wells of the supplied microplate. Samples, standards, or controls are then added into these wells and bind to the immobilized (capture) antibody. The sandwich is formed by the addition of the second (detector) antibody, a substrate solution is added that reacts with the enzyme-antibody-target complex to produce measurable signal. The intensity of this signal is directly proportional to the concentration of target present in the original specimen. Rigorous validation Each manufactured lot of this ELISA kit is quality tested for criteria such as sensitivity, specificity, precision, and lot-to-lot consistency. See manual for more information on validation.
The beta-interleukin-1 (IL-1 beta) is a proinflammatory cytokine expressed by monocytes, macrophages, and dendritic cells. IL-1 beta is synthesized in response to inflammatory stimuli as a 31 kDa inactive proform that accumulates in cytosol. The cleavage of pro-IL-1 beta in the active 17 kDa protein requires the activation of inflammasomas, which are multiprotein complexes that respond to pathogens, stress conditions and other hazard signals. Activation of the inflammasoma triggers the treatment of the precursor of caspase-1 in its active form, which in turn cleaves the pro-IL-1 beta. IL-1 beta does not have a signal sequence peptide for the conventional ER/Golgi pathway and is secreted along the caspase-1 via an alternative mechanism and understood incompletely. Although the beta-IL-1 is most often secreted as active, the secretion of the uncleavened protein can be detectable under certain biological conditions. The signals of the IL-1 beta through two receptors, IL-1RI and IL-1RII, both of which are shared with the IL-1 alpha. The activity of the IL-1 beta may be moderated by the IL-1 receptor antagonist (IL-1RA), a protein produced by many types of cells that blocks receptor binding by competitive inhibition. IL-1 beta plays an important role in defending the innate host by triggering the production of other proinflammatory cytokines in target cells and by triggering acute phase responses to infection and injury. High levels of d的IL-1 beta have been associated with many chronic inflammatory conditions of the beta-IL-1 neutralizing the potential therapeutic value of antibodies.